CT101a
/ Shanghai Zeke Biotech, Zhejiang University
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 16, 2023
NK Cell Therapy for AML
(clinicaltrials.gov)
- P1 | N=3 | Terminated | Sponsor: Zhejiang University | N=18 ➔ 3 | Trial completion date: Jun 2025 ➔ Apr 2023 | Recruiting ➔ Terminated | Trial primary completion date: Dec 2024 ➔ Aug 2022; A new study is planed to replace the current study due to IP upgrade
Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Acute Myelogenous Leukemia
1 to 1
Of
1
Go to page
1